Recognition and management of patients with OUD: Treatment, harm reduction and naloxone
Opioid use disorder (OUD) is a life-threatening and often iatrogenic disease. For anyone who uses opioids for treatment of chronic pain, it is expected that some patients will develop opioid use disorders. In some studies as many as 25% of patients on chronic opioids develop OUD. In this lecture, Dr. Stader describes how to recognize and screen for OUD, and makes a compelling case for why primary care clinicians have a duty to continue to care for patients who develop opioid use disorders. The lecture also explores the strong evidence behind medications for addiction treatment (MAT) and introduces how to start incorporating buprenorphine into clinical practice. Lastly, the lecture covers harm reduction and how to best utilize naloxone and counseling for overdose prevention.
This pre-recorded webinar, by speaker Don Stader, MD, FACEP, will take an estimated 75 minutes to complete.
Advanced Practice Clinicians
- Discuss screening for OUD in primary care practice.
- Analyze the benefits of medication for addiction treatment.
- Apply processes to incorporate buprenorphine prescribing into your practice.
- Identify strategies for harm reduction, especially the access to naloxone.
This is webinar 7 of 8 for the Compass Opioid Stewardship Certificate Program
Don Stader, MD, FACEP
Don Stader, MD, FACEP, is an emergency physician, opioid expert, film producer and innovator. He works at Swedish Medical Center in Englewood, CO, where he serves as the section chair of emergency medicine and associate ED medical director. Stader holds a medical degree with honors from Baylor College of Medicine and attended emergency medicine residency at Carolinas Medical Center. He is the Past President of the Colorado chapter of the American College of Emergency Physicians (COACEP) and former President of the Emergency Medicine Resident's Association (EMRA). He is also founder and past chair of Colorado ACEP's Opioid Task Force, Editor-in-Chief of COACEP's 2017 Opioid Prescribing and Treatment Guidelines and the leader of CO's CURE, an effort to create multidisciplinary opioid prescribing and treatment guidelines for the state of Colorado. Stader is the Senior Pain Management and Opioid Policy Physician Adviser for the Colorado Hospital Association and serves on multiple national and local committees addressing the opioid epidemic in Colorado and across the nation. He is the founder and chair emeritus of the nonprofit, The Emergency Medical Minute, which provides free online emergency medical education via podcasts and video.
Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and The Iowa HealthCare Collaborative. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: HCA Healthcare Continental Division designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support: This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure: HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose. Don Stader, MD, FAAEP discloses he is a consultant for OPISAFE/RX Assurance
- 1.25 AMA PRA Category 1 Credit™